Other studies that observed positive associations between adiponectin and CMD included patients with cardiometabolic conditions such as ischemic stroke [66], T2D [67], and non-alcoholic fatty liver disease [68], which aligns with our strong evidence of effect of the metabolic health condition on the association between adipokines and cIMT. This evidence concerns the gene ADIPOQ and ischemic stroke.